Clinical trial
Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous…
NCT00168038 · CSL Behring, Industry · Completed
Key facts
| NCT number | NCT00168038 |
|---|---|
| Title | Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10 |
| Official title | An Open-label, Multicenter Study on the Efficacy and Safety of IgPro10 in Patients With Chronic Immune Thrombocytopenic Purpura (ITP) |
| Lead sponsor | CSL Behring, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Immune Thrombocytopenic Purpura |
| Intervention type | Biological |
| Interventions | Immunoglobulin Intravenous (Human) |
| Enrollment | 58 |
| Start date | Dec 1, 2004 |
| Completion | Feb 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Nov 23, 2011 |
| Countries | Germany, Italy, Poland, Russia, Ukraine, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: